Back to search
FDAFDA · Food and drugs·Recall number D-0292-2025

METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MG, 180 TABLETS, Packaged BY: A-S Medication Solutions, Libertyville, IL 60048 NDC 50090-1494-3.

Published April 2, 2025 · Recall initiated: February 25, 2025

Summary

FDA records drug Class II recall D-0292-2025, published April 2, 2025 and initiated February 25, 2025. Recalling firm: A-S Medication Solutions LLC; Status: Ongoing; Reported quantity: 411 180-count bottles; Lot: Lot# 4260340; Exp.12/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablets/Capsules.

What to do

Voluntary: Firm initiated · Letter

Get an email if METFORMIN HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
METFORMIN HYDROCHLORIDE
Manufacturer
A-S Medication Solutions LLC
Distributor
Nationwide in U.S.
Lot
Lot# 4260340; Exp.12/31/2025.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MG, 180 TABLETS, Packaged BY: A-S Medication Solutions, Libertyville, IL 60048 NDC 50090-1494-3. recalled?

Yes. FDA published recall D-0292-2025 on April 2, 2025. Reported hazard: Presence of Foreign Tablets/Capsules.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: METFORMIN HYDROCHLORIDE.